Other languages Sankyo Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
1,664 ^JPY	+1.87%		+1.93%	+1.15%

Apr. 25	AstraZeneca upbeat as cancer drugs underpin sales growth	AN
Apr. 08	AstraZeneca hails neurological data for Ultomiris, Soliris	AN

AstraZeneca upbeat as cancer drugs underpin sales growth	Apr. 25
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...	Apr. 25
AstraZeneca hails neurological data for Ultomiris, Soliris	Apr. 08
AstraZeneca's, Daiichi's Enhertu receives US FDA approval	Apr. 08
AstraZeneca, Daiichi make US progress with licence approvals	Apr. 03
AstraZeneca and Daiichi make US progress with latest licence approvals	Apr. 02
Bitcoin: verso nuove vette - Crypt On It	Mar. 07
AstraZeneca's breast cancer treatment blocked for NHS use in England	Mar. 05
AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment	Mar. 04
Nikkei extends record rally on pharma boost	Feb. 25
Nikkei hits record high as index heavyweights advance	Feb. 25
AstraZeneca completes USD1.1 billion acquisition of Icosavax	Feb. 19
AstraZeneca celebrates Tagrisso approval and new data	Feb. 19
Sankyo Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Grow	Feb. 07
Sankyo Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023	Feb. 07
SANKYO Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	Feb. 07
SANKYO Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 07
Japan's Nikkei slips after Fed chair signals delay in rate cut	Jan. 31
AstraZeneca, Daiichi's Enhertu granted priority review in US	Jan. 29
AstraZeneca ups guidance; inks licence deal for obesity drug	Nov. 09

No results for this search